Although hundreds of thousands of patients with atherosclerotic cardiovascular disease (ASCVD) are eligible for high-intensity statin therapy, most are not using the drugs, UT Southwestern Medical Center researchers report.
Agreement aims to improve patient care and outcomes on a global scale
Not for public release
This news release is embargoed until 4-Sep-2023 5:00 PM EDT
Released to reporters: 29-Aug-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 4-Sep-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Los investigadores de Cedars-Sinai son líderes en la innovación y el uso del reemplazo valvular aórtico transcatéter (TAVR) con válvulas expandibles con balón. Ahora demuestran que volver a hacer los procedimientos TAVR son seguros y eficaces en comparación con situaciones en las que pacientes con perfiles de riesgo similares se someten al mismo procedimiento por primera vez.
The Ohio State University Wexner Medical Center on Wednesday randomized the first patient in the world in a clinical trial evaluating the effectiveness of a device designed to alleviate heart failure symptoms.
Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the first time.
A Binghamton University, State University of New York researcher will lend his data-analysis skills to a landmark study of Latina women funded by the National Institutes of Health.
Your daily dose of omega-3s may not be doing what you think it is. Most fish oil supplements on the market today have labels boasting health benefits that aren’t supported by clinical data, according to a study published in JAMA Cardiology by researchers at UT Southwestern Medical Center.
A study of more than 83,000 questionnaires by women ages 50-79, found more than 25% developed irregular heart rhythms, known as atrial fibrillation, which may increase their risk for stroke and heart failure.
A multi-site, five-year study led by a MedStar Heart & Vascular Institute cardiologist and fellow researchers from across the country have demonstrated the benefits of routine genetic testing for patients with advanced disease from dilated cardiomyopathy (DCM), a disease of the heart muscle and their at-risk family members.
CobiCure Medical Technologies, a non-profit pediatric initiative, part of the Advancium Health Network, announced today its continued commitment to solving the unmet needs in pediatric medical technologies.
A new drug offers a breakthrough world first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke, announced today by study lead Professor Stephen Nicholls, Director of the Monash University’s Victorian Heart Institute and Victorian Heart Hospital.
The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trials. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
Investigators from the Smidt Heart Institute at Cedars-Sinai are one step closer to helping individuals catch a sudden cardiac arrest before it happens, thanks to a study published today in the peer-reviewed journal The Lancet Digital Health.
Patients living with one of the UK’s most common heart rhythm conditions are 50% less likely to die from a heart attack or stroke than they were at the start of the millennium, new research has found.
Dr. Yoon Ki Joung and Dr. Juro Lee of the Biomaterials Research Center at the Korea Institute of Science and Technology (KIST), together with Prof. Hun-Jun Park and Dr. Bong-Woo Park of the Catholic University of Korea College of Medicine, have developed a new treatment for myocardial infarction that uses nanovesicles derived from fibroblasts with induced apoptosis to modulate the immune response.
Throughout the European Society of Cardiology (ESC) Congress August 25-28, 2023, in Amsterdam, experts from the Smidt Heart Institute at Cedars-Sinai will be available to discuss advances and innovations in cardiology, including some of the most recent and promising breakthroughs in research.
Fewer than half of people worldwide who have already had one heart attack or stroke take daily aspirin to prevent a second one, according to a new study led by researchers at Washington University School of Medicine in St. Louis.
Clopidogrel is a commonly prescribed medication used to prevent further heart attacks after an initial event. It needs to be activated in the body to be effective.
What if we could identify the earliest warning signs of cardiovascular disease from a simple saliva sample? Scientists think they have found a way to do so. Gum inflammation leads to periodontitis, which is linked with cardiovascular disease.
E. Dale Abel, MD, PhD, chair of the Department of Medicine at the David Geffen School of Medicine at UCLA and executive medical director of the UCLA Health Department of Medicine has received the Endocrine Society Fred Conrad Koch Lifetime Achievement Award, the group’s highest honor, recognizing exceptional contributions to the field of endocrinology.
Parents can be so protective of a child with congenital heart disease they often forget what comes next. When should they start learning to take care of their own condition? Two Penn State Health experts share their views.
Pain one year following a heart attack is common and linked with a higher likelihood of death within the next 8 years, finds new study in the Journal of the American Heart Association.
Researchers from the University of California, Irvine have just published a study that projects 93 million U.S. adults that are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy.
La inteligencia artificial (IA) está capturando la imaginación del público a medida que el ritmo de la innovación se acelera considerablemente y las herramientas de IA fáciles de usar ofrecen nuevas posibilidades para transformar industrias enteras.
Not for public release
This news release is embargoed until 14-Aug-2023 5:00 PM EDT
Released to reporters: 8-Aug-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 14-Aug-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
A new American Heart Association scientific statement highlights evidence that supports shared decision-making, a term that describes the process of ensuring patients have the knowledge and tools to make decisions about their health in collaboration with their professional health care team.
Artificial intelligence (AI) is capturing the public imagination as the pace of innovation accelerates sharply and easy-to-use AI tools offer new possibilities to transform whole industries.
Hypertrophic cardiomyopathy can cause sudden death at any age – but particularly in young people. A Penn State Health heart surgeon discusses prevention.
The impact of particulate matter air pollution on death and disability is on the rise worldwide, according to new research published today in the Journal of the American Heart Association.
A remarkable breakthrough, a collaborative team of researchers has unveiled a miniature human heart model that could potentially transform drug testing and cardiovascular research.
A new survey of cardiovascular care centers in the U.S. and Canada found that there are not enough resources to meet the needs for pediatric preventive cardiology care.
A study from Ann & Robert H. Lurie Children’s Hospital of Chicago has shown that prenatal diagnosis, or diagnosis before a baby is born, is associated with earlier surgery for babies with congenital heart defects, the most common birth defects affecting nearly 1% of all live births. The association was demonstrated for critical defects (when heart surgery is required before the infant leaves the hospital) and certain types of noncritical defects, which constitute about 75% of all congenital heart defects.
The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company Ferrer, has been included by the World Health Organization (WHO) in its List of Essential Medicines.
An international research team has identified an important treatment target that could help prevent patients from developing a serious heart condition in the future.
MedStar Washington Hospital Center has again been recognized as one of the top 50 cardiovascular centers in the country by U.S. News & World Report's Best Hospitals" list. MedStar Washington's Cardiology, Heart & Vascular Surgery program is tied for the No. 33 spot nationwide in this year’s rankings. It is the only nationally recognized heart and vascular program of its kind in the Washington region. MedStar Washington was also rated as high performing in two adult specialties: Gastroenterology & GI Surgery and Geriatrics and 15 common procedures or conditions.
An analysis of data from seven studies involving more than 19,000 adults in the United States, Korea and Japan found a clear association between increases in systolic (top-number) blood pressure and the number of alcoholic beverages consumed daily.
Psychosocial stress profoundly affects people’s lives globally, not least because it can be a critical risk factor for cardiovascular disease. Thanks to an $11.5 million award renewal from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, distinguished researchers at the Icahn School of Medicine at Mount Sinai and elsewhere aim to gain a deeper understanding of how stress influences cardiovascular health.
A study from the University of Illinois Urbana-Champaign and CIATEJ in Guadalajara, Mexico, explored the composition of seed coat extracts from black and pinto bean varieties unique to the Chiapas region of Southern Mexico.
Key Takeaways:Sudden cardiac arrest is a leading cause of death among young athletes.Pre-participation heart screenings are advised for athletes ages 12 and above.Cardiac tests can detect 99% of abnormalities.Heart defects don’t prohibit kids from playing sports.The fact that sudden cardiac arrest is a leading cause of death in young athletes seems illogical, provoking an obvious question: “That’s the point,” says Children’s Hospital Los Angeles cardiologist Paul Kantor, MBBCh, MSc, FRCPC.
Research from Ann & Robert H. Lurie Children’s Hospital of Chicago found that direct injection of neonatal mesenchymal stem cells, derived from heart tissue discarded during surgery, reduces intestinal inflammation and promotes wound healing in a mouse model of Crohn’s disease-like ileitis, an illness marked by chronic intestinal inflammation and progressive tissue damage.